Authors
Malofei A.M.1, 2, Romanikhin A.I.1, Ablitsov A.Yu.2
1 City Clinical Hospital №23 named. I. V. Davydovsky, Moscow
2 Pirogov National Medical and Surgical Center, Moscow
Abstract
The SARS-CoV-2 pandemic has been characterized by a large number of complications involving all human organs and systems. For the surgical community, purulent and destructive pulmonary and pleural diseases occurring against the background of initially occurring or newly diagnosed coronavirus infection (NCI) are of the greatest clinical and scientific interest. Despite the considerable amount of accumulated information about the causative agent, peculiarities of pathogenesis, clinical course and treatment of NKI, the consensus about the peculiarities of management of patients with purulent complications of lungs and pleura has not been reached so far. Treatment decisions are made on a case-by-case basis.
Although SARS-CoV-2 pandemic is officially over, elimination of the pathogen from the human population is impossible, which indicates the need for further collection and analysis of information on all cases of purulent-destructive diseases of lungs and pleura against the background of NKI in order to identify the features of their course and improve treatment and diagnostic measures in this group of patients.
Keywords: pleural empyema, covid-associated pneumonia, videothoracoscopy, lung gangrene, new coronavirus infection.
References
1. Kanai E, Matsutani N. Management of empyema: a comprehensive review. Curr Chall Thorac Surg. 2020; 2: 38. doi: 10.21037/ccts. 2020.03.02.
2. Davies HE, Davies RJ, Davies CW. BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010; 65(2): 41-53. doi: 10.1136/thx.2010.137000.
3. Hecker E, Hecker HC, Hecker KA. Pleuraempyem: Behandlungsstrategien unter Berücksichtigung der Ätiologie. Zentralblatt für Chirurgie. 2013; 138(3): 353-379. doi: 10.1055/s-0032-1328638.
4. Klopp M, Pfannschmidt J, Dienemann H. Treatment of pleural empyema. Chirurg. 2008; 79(1): 83-94. doi: 10.1007/s00104-007-1429-y.
5. Kolesnikov IS, Lytkin MI. Pulmonary and pleural surgery: Guidelines for physicians. M.: Medicine. 1988. Р.384. (In Russ.)
6. Coronavirus disease 2019 (COVID-19): situation report — 51. World Health Organization. 2020.
7. Telyashov AD, Gallyamov EA, Khrupkin VI, et al. Methods of treatment of pleuropulmonary complications of covid-associated pneumonia. Voyenno-meditsinskiy zhurnal. 2021; 350(10): 37-43. (In Russ.)
